The World Health Organization (WHO) has advised against restricting travel to, or trade with, countries affected by Ebola, on the same day Kenya announced that a man had died of the disease in Nairobi.
The man was a Kenyan who had lived in the Democratic Republic of Congo (DRC) for seven years.
He died on the night of 5 October 2026, according to a Ministry of Health press release dated 6 October 2026 and signed by Health Cabinet Secretary Aden Duale.
It is the first imported Ebola case Kenya has confirmed, and tests showed he was infected with the Bundibugyo virus, one of the viruses that cause Ebola.
World Health Organization chief Tedros Adhanom Ghebreyesus said in a statement published on the social media platform X on 6 October 2026 that the agency advises against "any restriction of travel to, or trade with, the affected countries based on the currently available information.''
Tedros said the agency is supporting the governments of Kenya, the DRC and Uganda with contact tracing, surveillance and screening, so that possible cases are found quickly and the virus does not spread further.
He added that the agency keeps watching travel and trade measures linked to the epidemic and will verify them where necessary, and sent condolences to the man's family.
According to Kenya's Ministry of Health, the man fell ill about a month before the 6 October announcement and was treated at several hospitals in the DRC.
He travelled by road to Kampala, Uganda's capital, and boarded Jambo Jet flight 8523 to Nairobi, landing at Jomo Kenyatta International Airport at 1:10 pm on Saturday 3 October.
The ministry said he went through the normal public health screening at the airport's Port Health and immigration desks.
A relative and a friend then took him by car straight to Nairobi Hospital, where he was placed in a separate room in the accident and emergency department and later moved to the hospital's East Wing Isolation Facility.
The ministry listed his symptoms as fever, chills, deep tiredness and weakness, muscle pain, painful swallowing, a sore throat and bleeding under the skin at injection sites.
His doctor suspected a viral haemorrhagic fever, a group of illnesses that cause fever and bleeding, because of those signs and his travel from the DRC.
A sample tested positive for Bundibugyo Ebola at two laboratories, the National Virology Reference Laboratory and the KEMRI laboratory.
He was given supportive treatment but died.
.jpeg)





